Epidemiology and prevention of coronary heart disease in families

American Journal of Medicine

Volumn 108, Issue 5, 2000, Pages 387-395

  Higgins, Millicent ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FAMILY; FAMILY HISTORY; FEMALE; FOLLOW UP; GENETICS; HERITABILITY; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING;

CORONARY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; RISK FACTORS; UNITED STATES;

EID: 0034177481     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00409-X     Document Type: Review

References (59)

1. Kannel W.B., Dawber T.R., Kagan A. Factors of risk in the development of coronary heart disease six year follow-up experience. The Framingham Study . Ann Intern Med. 55:1961;33-50.
2. Thomas C.B., Cohen B.H. The familial occurrence of hypertension and coronary artery disease with observations concerning obesity and diabetes. Ann Intern Med. 5542:1955;90-127.
3. Keys A. The epidemiology of coronary heart disease in epidemiology and prevention. Council Newsletter, No. 52, Spring 1995. American Heart Association.
4. Deutscher S., Epstein F.H., Kjelsberg M.O. Familial aggregation of factors associated with coronary heart disease. Circulation. 33:1966;911-924.
5. Last, JM, ed. A Dictionary of Epidemiology, 3rd ed. New York: Oxford University Press, 1995.
6. Friedlander Y. Familial clustering of coronary heart disease a review of its significance and role as a risk factor for the disease . Goldbourt U., de Faire U., Berg K. Genetic Factors in Coronary Heart Disease. 1994;Kluwer Academic Dordrecht, Boston.
7. Hunt S.C., Williams R.R., Barlow G.K. A comparison of positive family history definitions for defining risk of future disease. J Chronic Dis. 39:1986;809-821.
8. Marenberg M.E., Risch N., Berkman L.F., Floderus B., de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. NEJM. 330:1994;1041-1046.
9. National Heart Lung, and Blood Institute. Framingham Study: an epidemiological investigation of cardiovascular disease. Section 34 Framingham Heart Study, 30 year follow-up. Washington, DC, National Technical Information Service. 1987 PB 87-1774-99; NIH Publication No. 87-2703.
10. Higgins M., Province M., Heiss G., et al. NHLBI Family Heart Study objectives and design . Am J Epidemiol. 143:1996;1219-1228.
11. Pankow J.S., Folsom A.R., Province M.A., Rao D.C., Eckfeldt J., Heiss G. Family history of coronary heart disease and hemostatic variables in middle-aged adults. Thromb Haemost. 77:1997;87-93.
12. Pereira MA, Schreiner PJ, Pankow JS, et al. The Family Risk Score for coronary heart disease: associations with lipids, lipoproteins and body habitus in a middle-aged bi-racial cohort. The ARIC Study. Ann Epidemiol. (in press).
13. Bensen J.T., Li R., Hutchinson R.G., Province M.A., Tyroler H.A. Family history of coronary heart disease and pre-clinical carotid artery atherosclerosis in African-Americans and whites the ARIC study . Genet Epidemiol. 16:1999;165-178.
14. Silberberg J., Wlodarczyk J., Robertson R., Dear K. Comparison of family history measures used to identify high risk of coronary heart disease. Genet Epidemiol. 16:1999;165-178.
15. Liao D., Myers R., Hunt S., Shahar E., Paton C., Burke G. Familial history of stroke and stroke risk. The NHLBI Family Heart Study. Stroke. 28:1997;1908-1912.
16. Myers R.H., Kiely D.K., Cupples A., Kannel W.B. Parental history is an independent risk factor for coronary artery disease the Framingham Study . Am Heart J. 120:1990;963-969.
17. Li R., Bensen J.T., Hutchinson R.G., Province M.A. Family risk score as a predictor of cardiovascular disease ARIC Study and NHLBI Family Heart Study . Genet Epidemiol. 16:1999;165-178.
18. Eaton C.B., Bostom A.G., Yanek L., et al. Family history and premature coronary heart disease. J Am Board Family Practice. 9:1996;312-318.
19. Hong Y., Province M.A., Rich S.S., et al. Familial clustering of features of multiple metabolic syndrome with special reference to PAI-1 the NHLBI Family Heart Study . Circulation. 99:1999;115.
20. King R.C., Stansfield W.D. A Dictionary of Genetics. 1997;Oxford University Press, New York.
21. Hunt S.C., Hasstedt S.J., Kuida H., Stults B.M., Hopkins P.N., Williams R.R. Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. Am J Epidemiol. 129:1989;625-638.
22. Ellison RC, Myers R, Zhang Y, et al. Effects of similarities in lifestyle habits on the familial aggregation of HDL- and LDL-cholesterol. The NHLBI Family Heart Study. Am J Epidemiol. (in press).
23. Reducing the Health Consequences of Smoking. 25 Years of Progress. A Report of the Surgeon General. 1989; DHHS Publication No. (CDC) 89-8411.
24. Weidner G, Rice T, Knox SS, et al. Familial resemblance in hostility. The NHLBI Family Heart Study. Psychosom Med. (in press).
25. Pederson N.L., Liechtenstein P., Plomin R., de Faire U., McClearn G.E., Mathews K.A. Genetic and environmental influences for type A-like measures and related traits a study of twins reared apart and twins reared together . Psychosom Med. 51:1989;428-440.
26. Sackett D.L., Anderson G.D., Milner R., Feinleib M., Kannel W.B. Concordance for coronary risk factors among spouses. Circulation. 52:1975;589-595.
27. Knuiman M.W., Divitini M.L., Welborn T.A., Bartholomew H.C. Familial correlations, cohabitation effects and heritability for cardiovascular risk factors. Ann Epidemiol. 6:1996;188-194.
28. Heller D.A., de Faire U., Pedersen N.L., Dahlen G., McClearn G.E. Genetic and environmental influences on serum lipid levels in twins. NEJM. 328:1993;1150-1156.
29. Hopkins P.N., Williams R.R., Hunt S.C. Magnified risks from cigarette smoking for coronary prone families in Utah. West J Med. 141:1984;196-202.
30. Khaw K.T., Barrett-Connor E. Family history of heart attack a modifiable risk factor . Circulation. 74:1986;239-244.
31. Hopkins P.N., Wu L.L., Wu J., et al. Higher plasma homocysteine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease. Arterioscler Thromb Vasc Biol. 9:1995;1314-1320.
32. Williams RR, Hopkins PN, Wu LL, Hunt SC. Applying genetic strategies to prevent atherosclerosis. In: Khoury MJ, Burke W, Thomson E, eds. Genetics and Public Health. New York: Oxford University Press. (in press).
33. Genest J.J. Jr, Martin-Munley S.S., McNamara J.R., et al. Familial lipoprotein disorders in patients with premature coronary heart disease. Circulation. 85:1992;2025-2033.
34. Boushey C.J., Beresford S.A.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for occlusive atherosclerosis. JAMA. 472:1995;1049-1057.
35. Graham I.M., Daly L.E., Refsum H.M., et al. Plasma homocysteine as a risk factor for vascular disease. The European concerted action plan. JAMA. 277:1997;1775-1781.
36. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase and plasma homocysteine concentrations. Circulation. 93:1996;7-9.
37. McGill H.C., McMahan C.A., Malcom G.T., Oalmann M.C., Strong J.P. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The pathobiological determinants of atherosclerosis in youth. Arterioscl Thromb Vasc Biol. 17:1997;95-106.
38. Hixon J.E. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler Thromb. 11:1991;1237-1244.
39. Hopkins P.N., Hunt S.C., Schreiner P.J., et al. Lipoprotein (a) interactions with lipid, and non-lipid risk factors in patients with early onset coronary artery disease. Results from the NHLBI Family Heart Study. Atherosclerosis. 141:1998;333-345.
40. Hunt S.C., Cook N.R., Oberman A., Cutler J.A., Hennekens C.H., Allender P.S. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension. Trials of hypertension prevention. Hypertension. 32:1998;293-401.
41. Carmena R., Roederer G., Mailloux H., Lussier-Cacan S., Davignon J. The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism. Metabol Clin Exper. 42:1993;895-901.
42. Kuivenhoven J.A., Jukema J.W., Zwinderman A.H., et al. The role of a common variant of the cholesterol ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. NEJM. 338:1998;86-93.
43. U.S. Bureau of the Census Statistical Abstract of the United States: 1997. Washington, DC.
44. Leach E. BBC Reith lectures. Listener, November 1967.
45. Holtzman NA, Watson MS, eds. Final report of the Task Force on Genetic Testing. Promoting Safe and Effective Genetic Testing in the United States. NIH-DOE Working Group on ELS Implications of Human Genome Research. National Human Genome Research Institute, 1997.
46. Bensen J.T., Liese A.D., Rushing J.T., et al. Accuracy of proband reported family history. Gen Epidemiol. 17:1999;141-150.
47. National Center for Health Statistics. Health United States, 1998. Hyattsville, MD.
48. Higgins M. How to estimate and reduce coronary heart disease risk in women. Cardiol Rev. 5:1997;199-207.
49. American Heart Association First Heart Attack Risk Test. American Heart Association, Dallas, TX. Provided as an educational service by Bristol-Myers Squibb Company.
50. Wilson P.W.F., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation. 97:1998;1837-1847.
51. National Center for Health Statistics. Healthy People 2000 Review. US Department of Health and Human Services. Publication No. (PHS) 98-1256, 1997.
52. Williams R.R., Hamilton-Craig I., Kostner G.M., et al. MED-PED. An integrated genetic strategy for preventing early deaths. Berg K., Boulyjenkov V., Christen Y. Genetic Approaches to Noncommunicable Diseases. 1996;Springer-Verlag, Berlin, Heidelberg.
53. Goble A., Jackson B., Philips P., Oliver R.G., Worcester M.C. The Family Atherosclerosis Risk Intervention Study (FARIS). Aust NZ J Med. 27:1997;568-577.
54. Knutsen S.F., Knutsen R. The Tromsø Survey the Family Intervention Study. The effect of intervention on some coronary risk factors and dietary habits: a 6-year follow-up . Prev Med. 20:1991;197-212.
55. Randomized controlled trial evaluating cardiovascular screening, and intervention in general practice. principal results of Br family heart study. Family Heart Study Group. BMJ 1994;308:313-320.
56. Pyke S.D., Wood D.A., Kinmonth A.L., Thompson S.G. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. The Br Family Heart Study. Arch Fam Med. 6:1997;354-360.
57. Epstein L.H., Valeski A., Wing R.R., McCurley J. Ten-year outcomes of behavioral family-based treatment for childhood obesity. JAMA. 264:1990;2519-2523.
58. Eaton C.B. Family-centered preventive counseling for coronary heart disease risk factors. Arch Fam Med. 6:1997;360-362.
59. Missed opportunities in preventive counseling for cardiovascular disease - United States, 1995. MMWR. 1998;47:91-95.